Skip to content
thestock.space

Alkali Metals (ALKALI) had a P/E of 32.3× on 6 Nov 2026, above the industry P/E of 22.1×, and the shares are 24% below their 52-week high. Its ROCE of 10% is the second-lowest among the 7 largest Specialty Chemicals peers, and sales grew 2.5% a year over 3 years while net profit fell 42%. Its dividend yield is 1.2%, and debt is 0.49× equity. It is a small-cap company with a market cap of ₹82 Cr, ranked 154th of 204 Specialty Chemicals companies by market cap; the shares fell 11% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Sep 2026.How we calculate this

past year
Open
₹78.69
Day high
₹81.72
Day low
₹76.11
Prev. close
₹78.69
Volume
3.1K

Health check

1 fair · 5 to check
  • ReturnsBehind

    −11.4% over a year, better than 0 of 7 peers.

  • Price tagPricier

    P/E 32.3 vs industry 22.1.

  • GrowthSlow

    Sales +2.5%, profit −42.4% a year over 3 years.

  • ProfitabilityWeak

    ROCE 10.5% vs peer median 24.4%.

  • Balance sheetFair

    Debt 0.49× equity, interest covered 2.9×, Piotroski 8 of 9.

  • Red flags1 to check

    Return on equity is low at 6.0%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Specialty Chemicals

203 listed peers. Screen the industry

Small cap

₹82 Cr, #154 of 204 in its industry by size.

Moves with the market

Beta 0.84 vs the NIFTY 50: tracks the market closely.

Key metrics

Last 12 months to Sep 2026: sales ₹98 Cr · profit ₹3 Cr
Market cap
₹82 Cr
Small cap
P/E
32.3
Industry 22.1
Price to book
1.90
Peers 13.33
Dividend yield
1.24%
ROE
6.0%
Peers 23.0%
ROCE
10.5%
Peers 24.4%
Debt to equity
0.49
Debt ₹21 Cr
EPS (TTM)
₹2.50
Face value ₹10
OPM (TTM)
6.9%
Net margin 2.6%
Sales growth
+45.2%
Latest quarter vs a year ago
Profit growth
n/a
Year-ago quarter not reported
Price to sales
0.83
EV/EBITDA 14.9

Strengths and risks

Strengths

  • Quarterly sales up 45.2% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Return on equity is low at 6.0%.

Derived automatically from reported figures. Not a recommendation.

About Alkali Metals

Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, carbazole, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine,…

Headquarters
Hyderabad
Employees
105
Sector
Basic Materials
ISIN
INE773I01017

Price range

52 weeks

₹46.80₹106.30

Today

₹76.11₹81.72
Avg volume (3M)
36.4K
1-year return
minus 11.4%
From 52-week high
minus 24.0%

Peers · Specialty Chemicals

Capital-heavy industry columns

Company
ASIANPAINTAsian Paints2,546.00plus 0.88%2,44,02550.535.024.4%18.9%0.211.1%plus 1.5%
SOLARINDSSolar Industries India18,608.00plus 0.48%1,68,38474.464.129.5%27.8%0.2212.4%plus 35.9%
PIDILITINDPidilite Industries1,579.00plus 1.63%1,60,82760.044.428.5%23.5%0.037.4%plus 6.8%
LINDEINDIALinde India6,859.00plus 8.73%58,496118.464.216.3%31.5%0.23–plus 5.4%
BERGEPAINTBerger Paints India478.35minus 5.28%55,77645.429.420.6%15.3%0.154.2%minus 6.0%
FLUOROCHEMGujarat Fluorochemicals4,665.50minus 0.94%51,25175.944.09.6%24.1%0.26−4.5%plus 28.0%
ACUTAASAcutaas Chemicals3,786.60plus 0.42%31,00170.964.127.7%39.4%0.0129.4%plus 105.6%
ALKALIAlkali Metals80.75plus 2.62%8232.312.210.5%6.9%0.492.5%minus 11.4%
Median of 7 peers–0.48%58,49670.944.424.4%24.1%0.215.8%6.8%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrSep 25Dec 25Mar 26Jun 26Sep 26
18.824.928.717.627.3
18.625.222.617.926
0.2−0.36.1−0.31.3
1.0%−1.1%21.2%−2.0%4.7%
0.10.20.30.80.5
0.40.70.40.40.5
0.70.70.70.70.7
−0.9−1.45.3−0.60.6
––24.3%––
−0.9−1.44−0.60.6
-0.90-1.373.94-0.630.56

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+2.5%
Profit CAGR 3Y
−42.4%
EPS CAGR 3Y
−42.3%
ROE
6.0%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
86.482.382.393
–minus 4.7%0.0%+13.0%
76.573.482.684.8
9.98.9−0.38.2
11.5%10.9%−0.4%8.8%
0.80.11−0.2
2.62.52.31.8
4.34.64.12.9
−0.1−0.4−2.3−0.1
3.81.6−83.3
22.7%27.2%27.8%83.2%
2.91.1−5.80.6
–minus 61.2%minus 613.8%–
2.861.11-5.700.55

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
10.210.210.210.2
42.741.234.334.5
23.822.818.218.1
28.835.230.232.7
10610992.995.5
50.847.641.138.5
1.30.30.1–
110.60.6
1.1000.1
51.360.451.156.4
10610992.995.5

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
11.26.35.22.8
−3.1−1.6−0.7−0.3
−9−5.7−4.5−2.5
−0.9−1.100
−3.1−1.7−1.3−0.3
84.63.92.5
−2−2−1−0.5

Shareholding pattern

Source: NSE filings
69.6%
promoters
  • Promoters69.59%
  • Public30.41%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202669.59%30.41%0.00
30 Jun 202669.59%30.41%0.00
31 Mar 202669.59%30.41%0.00
31 Dec 202569.59%30.41%0.00
30 Sep 202569.59%30.41%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you